Clever Culture Systems reports three completed sales as expected first-half pipeline reaches eight units
CC5: $0.019 +2.70% · MC: $36M
Clever Culture Systems says three APAS Independence sales were completed and fully invoiced in the first quarter of FY27, while it expects first-half sales and new evaluations to reach eight units, matching the full-year FY26 total sold to pharmaceutical customers. Two existing global pharmaceutical customers are expected to progress to purchases, and a new top-20 pharmaceutical company is expected to begin a paid evaluation; these opportunities remain subject to conversion.

Comments